DMARD


Also found in: Thesaurus, Medical, Legal, Acronyms, Encyclopedia, Wikipedia.
Related to DMARD: ACR20
Translations

DMARD

abbr disease-modifying antirheumatic drug. V. drug.
Mentioned in ?
References in periodicals archive ?
5 per cent of patients on DMARDs developed dementia - compared with three per cent of those who did not.
Both vaccines were safe and well tolerated by all patients, including those taking a DMARD.
Researchers found lower adherence to sulfasalazine (30 percent) compared to all other DMARDs (40 percent), and speculated that daily therapy with hydroxychloroquine and sulfasalazine, which can require up to six tablets daily, was associated with lower persistence and adherence than once-weekly MTX injections and TNFi once-weekly or less frequent dosages.
Kevzara may be used as monotherapy or in combination with MTX or other conventional DMARDs.
Patients of RA taking DMARD therapy were enrolled from Rheumatology OPD, Military Hospital, Rawalpindi, after taking their written informed consent.
13) Given the inconclusiveness of these data, it is imperative that the decision to maintain patients on their DMARDs perioperatively be thoroughly discussed with the patient by the health care team in order to assess the risks and benefits of continuing DMARD therapy.
Methotrexate is a synthetic DMARD, considered as a primary anchor drug in RA management.
In this era of DMARD and availability of biological agents for treatment of rheumatological disorders, the prevalence of extra-articular manifestations has declined, leading to a change in the natural course and presentation of the disease.
030), as well as in the delay from first rheumatology visit to the start of DMARD therapy (before 1986, 32 months; 1987-1989, 21 months; 1990-1993, eight months; 1994-1997, one month; p<0.
Before the start of the program, measures were high for the percentage of RA patients and the percentage of patients with active RA on a DMARD as well as the percentage of patients who had their LDLs checked.
Recognition of the importance of early initiation of DMARD therapy prompted the development of a new classification system that focuses on features of RA that occur at earlier stages and are associated with persistent and/or erosive disease.